CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation. - Wikidata - wikimedia - TriplyDB

CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.

CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.

http://www.wikidata.org/entity/Q34118698

about

In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulation Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs.Different maturation cocktails provide dendritic cells with different chemoattractive properties.The role played by alternative splicing in antigenic variability in human endo-parasites.CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection.Differential response of primary and immortalized CD4+ T cells to Neisseria gonorrhoeae-induced cytokines determines the effect on HIV-1 replication.Association of the CCR5 gene with juvenile idiopathic arthritis.Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression rates Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.An aberrant thymus in CCR5-/- mice is coupled with an enhanced adaptive immune response in fungal infection.Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo.Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation.CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial HIV RNA suppression and immune restoration: can we do better?Bone marrow from blotchy mice is dispensable to regulate blood copper and aortic pathologies but required for inflammatory mediator production in LDLR-deficient mice during chronic angiotensin II infusion Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study.CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infection Inflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage mediator production inhibition during thioglycollate elicited peritoneal inflammation.In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4 CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway.Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals.Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease.Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.Lysosomal phospholipase A2: a novel player in host immunity to Mycobacterium tuberculosis.Shikonin Suppresses Human T Lymphocyte Activation through Inhibition of IKK β Activity and JNK Phosphorylation Maraviroc reduces the regulatory T-cell frequency in antiretroviral-naive HIV-infected subjects.Production of LPS-induced inflammatory mediators in murine peritoneal macrophages: neocuproine as a broad inhibitor and ATP7A as a selective regulator.Double-edged genetic swords and immunity: lesson from CCR5 and beyond.In vitro effects of the CCR5 inhibitor maraviroc on human T cell function.Marked differences in CCR5 expression and activation levels in two South African populations.The intensity of immune activation is linked to the level of CCR5 expression in human immunodeficiency virus type 1-infected persons.Pseudolaric acid B suppresses T lymphocyte activation through inhibition of NF-kappaB signaling pathway and p38 phosphorylation.

P2860

Q24610713-9BD9ECB0-127A-4DB1-94E9-BF92C3923D14 Q27687272-D6ACF9B7-F759-4695-9F06-8A77C4C64C22 Q30315866-57D6D042-6CD0-4757-8701-E2080E0EA2CA Q33588936-2C109D46-579B-426A-80E7-D3CC2E4EE819 Q33839741-6B8237E0-B222-4A44-B695-E2859AB3BF62 Q33883419-245BFD23-B18D-4E74-A1AF-85AB55DD80C8 Q34282309-2D1305FE-0D04-43AD-B134-27C611E8DFC2 Q34763459-780D4831-D095-4A0B-8FC5-CAC9452EC893 Q34988294-53022BE1-E69E-4EC1-B4A4-24DD2D01A63F Q34994967-5BD2BACF-0664-4BCA-888A-5435B27406F9 Q35035564-E7530D9F-D6E6-4E62-A434-B931F0D236EA Q35143430-8AE7E5EA-4BA3-4508-81C9-44A875B97E9C Q35149267-75E47747-D296-4051-8F9F-6E532B4F373D Q35693333-7CA31C8B-8C20-4881-8FD6-160EDEEA2E53 Q35712284-AD7AEEE9-8245-4908-BFCA-820C9C38BB1B Q35867173-BCFF54E2-5996-47E0-8EEC-C90AFE5F74B6 Q35903447-10B31AE2-4772-46D5-A529-4313698704C5 Q36008317-9F166367-49E8-45FB-89E8-BB5A68B6B7AA Q36160526-E2570F9B-B72D-4BD4-9FB0-468B7924719D Q36179796-B06F786F-247A-4EEE-828F-06B1DC85FD34 Q36379230-21A625CE-D040-4FA5-8906-26C9B5C84B43 Q36381738-79C54DB2-344F-4CEB-AF39-DF6AD17E9A86 Q36434337-7648BB44-808D-4307-92CC-81CBCEFAA267 Q36771585-B4A64125-DEA4-47A4-BCFB-3E8DB47C5FAF Q36888917-3F5A47FF-460C-487B-A70E-C9DB9444D0A9 Q37348497-48958BDF-13EA-42BB-BC26-E318DEE96D82 Q37521828-2C97477A-81F1-4D66-B3EC-3CDE49DEBA65 Q37668003-E81EE5B5-F368-4FE7-9497-D4C1466AF4E6 Q37760665-1260072C-B27F-4A3D-9DF7-A315E7DDC4CE Q38066127-632B02E6-FFEC-44D7-99B5-8BC8A1FB0CA4 Q38702121-1A893912-C64C-4285-ADB1-0B94C770A768 Q39437874-CC2CF3B4-78CC-40F6-AE9A-17CE4D2B4355 Q41428122-7E300B50-45E7-45BF-A25D-31D037702E46 Q42222937-16AF7091-502E-4EE9-991B-FE2DC602D7F1 Q42711786-4795A826-AF9B-457B-B007-C9EC63D3F86D Q43066917-796A41D0-2862-4CD2-BAE3-85F331ADE23B Q44242057-15671EAD-42A4-41FD-AFCA-42E37C24B85D Q45015137-98A9B3D0-9065-497A-B0A9-809F1DC73172 Q45355735-674D41F6-49F8-4AD4-B2F0-02279A460A9E Q45977248-04CCC816-BDBF-4BFA-8E1F-E2608CCBC6A1

P2860

CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.

http://www.wikidata.org/entity/Q34118698

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

CCR5 expression levels influen ...... uring T lymphocyte activation.

@ast

CCR5 expression levels influen ...... uring T lymphocyte activation.

@en

CCR5 expression levels influen ...... uring T lymphocyte activation.

@nl

type

label

CCR5 expression levels influen ...... uring T lymphocyte activation.

@ast

CCR5 expression levels influen ...... uring T lymphocyte activation.

@en

CCR5 expression levels influen ...... uring T lymphocyte activation.

@nl

prefLabel

CCR5 expression levels influen ...... uring T lymphocyte activation.

@ast

CCR5 expression levels influen ...... uring T lymphocyte activation.

@en

CCR5 expression levels influen ...... uring T lymphocyte activation.

@nl

P1433

Q34118698-360AC63D-4C86-4814-962A-935ADFF83190

P1476

Q34118698-AA9FCD16-167D-4875-A307-75BAAC45D298

P2093

Q34118698-5CC65286-863E-4003-A8AD-F2C35A4A92E4

Q34118698-84A51570-FD2A-4EE7-A210-867F87231319

Q34118698-9EC82F47-B8F4-4408-8760-7A49A42B5DCF

Q34118698-A1EE6FAB-D75C-4C6E-A08F-7287F0A68924

Q34118698-AE2950B1-6CA5-4A96-8F65-5176EB14DAE5

Q34118698-B4A2BE56-E6D3-44B4-9421-9D6B0D8F23CB

Q34118698-C3C3E065-47E0-4016-AC5D-CB994F3AE301

Q34118698-DC755624-2F8B-4B07-AFE7-6235F67E8D49

Q34118698-E1D279E5-DD3E-4B55-886E-5E77628FF327

Q34118698-E43C6F65-0876-44F1-A33F-4601307EAF56

P2860

Q34118698-02EBB04C-EB39-444D-BE1D-B58C05AC9D76

Q34118698-087C4DAA-71DF-4BF8-AF8C-72981FBBFA3F

Q34118698-1428B8D8-C4DC-45D7-BA73-DE8252D3727A

Q34118698-1936F959-6E65-4545-A7D3-4F4F509B32A6

Q34118698-2E1FB3A4-264A-48B5-8D82-12776B3E39C1

Q34118698-30F14B1E-916E-45E1-96B9-990D6416EA38

Q34118698-353F75E3-FC14-45C8-BA44-5BC45C6C9959

Q34118698-3B3CDE5A-2E18-4A3F-BC7A-65B2E15A1F71

Q34118698-3BA71739-82ED-4ABC-A112-26C6C7EB702A

Q34118698-3BF47303-F907-413D-88F9-3B3D9263CE4C

P304

Q34118698-93A29080-D7F4-49F9-B15C-AF4955E1162F

P31

Q34118698-D7F96F2B-794E-4BCC-A483-81E1A5D8B220

P356

Q34118698-32E9F07F-C849-44F7-82A9-DF83AB7FC6FB

P407

Q34118698-5366A573-F46F-43DB-B5F4-FD770F90F24D

P433

Q34118698-795C31C5-07B7-430A-ACD7-B1FC0FB4305D

P478

Q34118698-5FE2E479-BBE9-4731-8EBC-D7FD214EF07F

P577

Q34118698-8F7806EC-7F9F-4104-A0E8-71F549C1B133

P5875

Q34118698-30F81EDF-99CD-42F0-8F6B-4B57D650AC6A

P698

Q34118698-FE287E8B-0E9A-4370-8C9B-9BB5EFE0796B

P932

Q34118698-50A24D78-8E65-4BFD-911F-9AF11E77BF1D

P356

JIMMUNOL.182.1.171

P1433

Journal of Immunology

P1476

CCR5 expression levels influen ...... uring T lymphocyte activation.

@en

P2093

Alvaro A Gaitan

http://www.w3.org/2001/XMLSchema#string

Derya Unutmaz

http://www.w3.org/2001/XMLSchema#string

Fabio Jimenez

http://www.w3.org/2001/XMLSchema#string

Jose F Camargo

http://www.w3.org/2001/XMLSchema#string

Kazi Begum

http://www.w3.org/2001/XMLSchema#string

Marlon P Quinones

http://www.w3.org/2001/XMLSchema#string

Scott VanCompernolle

http://www.w3.org/2001/XMLSchema#string

Seema S Ahuja

http://www.w3.org/2001/XMLSchema#string

Sowmya Srinivas

http://www.w3.org/2001/XMLSchema#string

Srinivas Mummidi

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation

CCR5 deficiency increases risk of symptomatic West Nile virus infection

NFAT proteins: key regulators of T-cell development and function

Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.

Digital NFATc2 activation per cell transforms graded T cell receptor activation into an all-or-none IL-2 expression.

P304

171-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.182.1.171

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23699230

http://www.w3.org/2001/XMLSchema#string

P698

19109148

http://www.w3.org/2001/XMLSchema#string

P932

2937277

http://www.w3.org/2001/XMLSchema#string